Clostridium sordellii: Causes, Symptoms, and Treatment

Clostridium sordellii is a soil-dwelling, spore-forming bacterium that causes rare but extremely deadly infections, most often in the form of toxic shock syndrome or tissue-destroying soft-tissue disease. The case-mortality rate in gynecologic infections reaches roughly 87.5%, and even with aggressive treatment, many patients with deep tissue infections do not survive. What makes this organism especially dangerous is how quickly it can overwhelm the body, often within days of an apparently routine medical event like childbirth or a minor wound, and how easily its early symptoms mimic less serious conditions.

Where Clostridium Sordellii Lives

C. sordellii is an anaerobic, gram-positive bacterium found primarily in soil and sewage, but it also lives quietly in the gastrointestinal tract and vagina of a small percentage of otherwise healthy people.¹ A large U.S. study of women found that about 3.4% carried C. sordellii at baseline, mostly in the rectum (about 3.2%) rather than the vagina (roughly 0.2%).² Those numbers mean the vast majority of people will never encounter this organism in a clinical setting, but the fact that it can already be present in a carrier’s body is part of what makes certain infections possible.

The bacterium forms spores, which are hardy dormant structures that survive harsh conditions including heat, drying, and many disinfectants. Spores allow C. sordellii to persist in the environment for long periods and resist sterilization methods that would kill most other bacteria. This durability becomes medically relevant in tissue banking and surgical settings, as standard antimicrobial solutions that are not specifically sporicidal may fail to eliminate it.

How People Get Infected

C. sordellii infections are not contagious from person to person in the way you might catch a cold. Instead, they occur when the bacterium or its spores gain access to a site where they can grow, particularly deep, oxygen-poor tissue. The main recognized risk scenarios fall into a few categories.

The most widely reported context is obstetric and gynecologic. The theory is that during childbirth, miscarriage, or medically induced abortion, the opening of the cervix allows bacteria that were already present in the vagina to migrate upward into the uterine cavity.³ There, in the oxygen-poor environment of the postpartum or postprocedural uterus, the organism can multiply rapidly and begin producing its toxins. Cases have been documented after natural childbirth, cesarean section, medically induced abortion using mifepristone and misoprostol, and spontaneous miscarriage.⁴

Outside of gynecologic settings, injection drug use is a major risk factor. A case series described necrotizing soft-tissue infections in people who inject drugs, where skin-popping or intramuscular injection introduces spores from contaminated surfaces directly into tissue.⁵ Traumatic wounds, surgical sites, and, less commonly, translocation through breaks in the gastrointestinal tract have also served as entry points.⁶

Another documented route involves musculoskeletal tissue allografts. An investigation into clostridium infections after tissue transplantation found that one tissue bank’s processing methods, which used a nonsporicidal antimicrobial solution, left spores intact. The infection rate from that bank’s sports-medicine tissues was 0.12%, rising to 0.36% for femoral condyles specifically, compared to effectively zero from other banks.⁷ Clostridium species remain among the organisms most frequently flagged as potentially disqualifying in deceased tissue donors, and their prevalence varies by the anatomical site recovered from, with lower extremity and pelvic tissues carrying the highest rates.⁸

Symptoms and What Makes Them Deceptive

The hallmark of a severe C. sordellii infection, and the reason so many cases are fatal, is toxic shock syndrome. The clinical picture can look puzzling because it often lacks the single sign most people associate with serious infection: fever. In a series of fatal cases after medical abortion, the patients presented with a rapid heart rate, dangerously low blood pressure, widespread swelling, and a dramatic rise in white blood cell count, yet no fever.⁹ That absence of fever is treacherous because it can lead patients and even clinicians to initially dismiss the illness as something less urgent.

Another laboratory finding that shows up early is hemoconcentration, where the proportion of red blood cells in the blood rises abnormally. This happens not because the body is making more red cells, but because fluid is leaking out of the bloodstream into surrounding tissues, concentrating whatever is left behind. Extreme swelling, or edema, often accompanies this shift. Within hours, the combination of fluid loss from blood vessels, plummeting blood pressure, and organ damage from the toxins can push the patient toward multiorgan failure. In soft-tissue infections, the affected area may show rapidly spreading tissue death, sometimes requiring emergency amputation to contain.

In the gynecologic context, one review of published cases found that nearly all patients with C. sordellii infection after childbirth or abortion followed a rapidly progressive course that included necrotizing infection of the uterine wall.⁴ The speed of deterioration is part of what makes this disease so lethal: one case report described death occurring in less than three days after hospital admission despite aggressive treatment.¹⁰

How the Toxins Cause Damage

The destructive power of C. sordellii comes primarily from a toxin called lethal toxin, or TcsL. This toxin belongs to a family of large clostridial glucosylating toxins that disable essential signaling proteins inside cells.¹¹ In plain terms, TcsL chemically modifies small molecular switches that cells depend on to maintain their shape, move, and communicate with neighbors. When those switches are jammed, cells lose the ability to hold themselves together.

The cells most vulnerable to this attack appear to be the ones lining blood vessels in the lungs. In animal studies, the lethal toxin caused a massive increase in lung vascular permeability, meaning the walls of blood vessels became leaky. Fluid poured out of the bloodstream into the chest cavity, leading to dehydration, a spike in the concentration of blood cells, oxygen deprivation, and ultimately heart and lung failure.¹² Under electron microscopy, the protein that normally glues neighboring endothelial cells together at their junctions had been displaced from the cell membrane to the interior of the cell, physically opening gaps between cells through which fluid could escape.

What is notable is how little classic inflammation accompanies this process. Traditional infections trigger a heavy inflammatory cascade, but the lethal toxin’s mechanism of killing is more structural: it destroys the integrity of the blood vessel wall directly. The immune system’s response is skewed as well. In a mouse model of C. sordellii infection, certain immune signaling molecules like G-CSF and IL-6 were markedly elevated, driving a massive but dysfunctional white blood cell response, while the molecules typically responsible for coordinating an effective fight against bacteria, such as TNF-alpha and IL-1 beta, were only mildly elevated.¹³ This helps explain the characteristic extreme white blood cell count seen in patients: the body mounts a vigorous but misdirected immune mobilization that fails to contain the infection.

How C. Sordellii Differs from C. Difficile

Because C. sordellii and C. difficile are close relatives that produce toxins from the same family, the comparison comes up often. The toxins share structural similarities and even cross-react with some antibodies, but they have diverged in important ways.¹⁴ The most clinically relevant difference involves which cellular targets the toxins attack and what kind of immune response they provoke. C. difficile toxins primarily inactivate a group of signaling proteins that triggers a strong inflammatory response, which is why C. difficile infection typically causes pronounced intestinal inflammation and diarrhea. C. sordellii’s lethal toxin, by contrast, inactivates a different set of signaling proteins that results in an anti-inflammatory effect, blocking the cell cycle and killing immune cells rather than riling them up.¹⁵

This difference in immune manipulation has real consequences. C. difficile causes plenty of misery but has a far lower mortality rate in most cases, partly because the inflammatory response, while destructive to the gut, is at least oriented toward fighting the infection. C. sordellii essentially blindsides the immune system: it suppresses the very responses that would help contain the bacteria, all while tearing apart blood vessel walls. The result is a disease that can go from vague malaise to fatal shock in a timeframe that leaves little room for intervention.

Diagnosis Is Often Too Late

One of the most frustrating aspects of C. sordellii infection is how difficult it is to diagnose in time to change the outcome. Standard blood cultures can identify the organism, but by the time cultures return positive, the patient may already be in irreversible shock. The absence of fever, a feature that distinguishes C. sordellii toxic shock from most other severe infections, can send clinicians down the wrong diagnostic path during the critical early hours.

In fatal cases, the only available specimens are often tissues preserved after death. Standard methods like immunohistochemistry can confirm the presence of clostridia in those tissues but cannot distinguish between species, which matters because treatment and epidemiologic tracking depend on knowing whether C. sordellii or C. perfringens (or both) was responsible. A PCR-based assay was developed to simultaneously detect both species from preserved tissue samples and showed perfect agreement with gold-standard methods in a study of 28 patients with toxic shock or uterine infection.¹⁶ This kind of rapid molecular identification is useful for postmortem investigation and public health surveillance, but the practical challenge remains getting clinicians to suspect the diagnosis early enough in living patients.

Treatment and Why Outcomes Remain Poor

The current approach to treating serious C. sordellii infections rests on three pillars: early recognition, surgical removal of dead and infected tissue, and antibiotics that shut down toxin production. Even with all three, mortality ranges from 30% to 100% depending on the type and location of the infection, and survivors frequently face life-altering amputations.¹⁷

On the antibiotic side, the organism is susceptible to a broad range of drugs. A hospital-based study of isolated strains found that all tested isolates were sensitive to beta-lactam antibiotics, linezolid, vancomycin, tigecycline, rifampicin, and chloramphenicol.¹⁸ So the problem is not antibiotic resistance, which is an unusual situation in an era of growing drug-resistant infections. The problem is that antibiotics alone cannot undo the damage already caused by toxins circulating in the bloodstream. By the time the bacteria are killed, the toxin-mediated destruction of blood vessel integrity and immune function may have progressed past the point of recovery.

Surgery plays a critical role precisely because of this toxin-driven pathology. In uterine infections, hysterectomy may be required to remove the source of toxin production. In soft-tissue infections, wide surgical excision of all necrotic tissue, sometimes including amputation, is standard. The one documented survivor of postpartum C. sordellii toxic shock had undergone a cesarean delivery and received aggressive surgical and medical intervention, a notable exception to the pattern of near-universal lethality.³

Given the limitations of conventional treatment, experimental approaches have focused on neutralizing the toxin directly. In a rodent model, injections of a monoclonal antibody targeting the lethal toxin protected animals from death during C. sordellii infection, suggesting that an anti-toxin strategy could someday supplement antibiotics and surgery in human patients.¹⁹ No such therapy has yet reached clinical use, but the concept is appealing because it would directly target the mechanism that makes these infections so rapidly lethal rather than relying solely on killing the bacteria after the toxin is already loose.

Toxin Genes Live on Transferable Plasmids

An intriguing wrinkle in C. sordellii biology is that not all strains of the bacterium are dangerous. The genes encoding its lethal toxin and hemorrhagic toxin are not built into the main chromosome, as they are in C. difficile. Instead, they sit on plasmids, which are small, separate loops of DNA that can be gained or lost independently.²⁰ A strain that does not carry the plasmid is essentially harmless, at least with regard to toxic shock. A strain that picks one up becomes a potential killer.

Worse still, these plasmids can transfer between bacteria. Researchers demonstrated that one of these toxin-carrying plasmids could move from one C. sordellii strain to another through bacterial conjugation, a process where two bacterial cells physically connect and share DNA. The genetic machinery enabling this transfer, called the cst locus, was found not just on C. sordellii plasmids but also on toxin-encoding plasmids from C. perfringens and C. botulinum, and within the genomes of some C. difficile strains.²¹ The implication is that this conjugation system is a shared piece of infrastructure among several dangerous clostridia, potentially allowing toxin genes and even antibiotic resistance genes to spread across species boundaries. For public health, this means that the virulence of C. sordellii is not a fixed trait of the species but something that can emerge in previously harmless strains through horizontal gene transfer.

C. Sordellii in Animals

Humans are not the only hosts. C. sordellii causes sudden death in livestock, particularly sheep. A study in the United Kingdom documented the organism in 37 sheep across 29 flocks that died suddenly over a two-year period. The worst disease and most severe lesions appeared in young lambs between four and ten weeks of age, while older lambs and adult ewes showed more variable and less dramatic signs.²² Separately, C. sordellii was recovered from the stomach contents of about 20% of lambs in a study of animals with abomasal bloat and ulcers, while none of the healthy control lambs carried the organism there.²³

The veterinary context matters beyond the farm. It confirms that C. sordellii is widely distributed in the environment and in animal gut flora, which helps explain how human infections occasionally arise from environmental exposure rather than person-to-person spread. Soil contaminated by animal waste is a plausible reservoir, and the organism’s ability to form persistent spores means it can survive in pastures, gardens, and any setting where soil contact occurs. For people with open wounds, particularly in rural or agricultural settings, awareness that a soil organism can cause this kind of fulminant disease is worth keeping in mind, even though the absolute risk of infection remains very low.